Markets and Vulnerable Patients

Health Law After the 2012 Act

Victoria Chico, Prof Tamara Hervey, Ruth Stirton, Amanda Warren-Jones

Research output: Contribution to journalEditorial

5 Citations (Scopus)

Abstract

In the popular imagination, the Health and Social Care Act 2012 is associated with a final ‘dismantling of the NHS as we know it’, by bringing competition, markets, contracts, and private interests in to the NHS. The Bill’s turbulent journey through the Parliamentary process shows how controversial such a move was understood to be. This process also took place at a time when, in view of numerous inquiries, public trust in the ability of English healthcare institutions
(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legal
scholars;, and regulation specialists to consider key issues raised by the Act.
Original languageEnglish
Pages (from-to)157-161
Number of pages5
JournalMedical Law Review
Volume22
Issue numberSpecial Issue: 2
DOIs
Publication statusPublished - 1 Jun 2014
Externally publishedYes

Fingerprint

health law
Lawyers
lawyer
act
Health
market
Ethicists
Delivery of Health Care
Imagination
Aptitude
dismantling
Contracts
nursing home
Nursing Homes
health
pharmaceutical
patent
EU
regulation
ability

Cite this

Chico, Victoria ; Hervey, Prof Tamara ; Stirton, Ruth ; Warren-Jones, Amanda. / Markets and Vulnerable Patients : Health Law After the 2012 Act. In: Medical Law Review. 2014 ; Vol. 22, No. Special Issue: 2. pp. 157-161.
@article{e6c717810371489fb00878ac08cd9bcf,
title = "Markets and Vulnerable Patients: Health Law After the 2012 Act",
abstract = "In the popular imagination, the Health and Social Care Act 2012 is associated with a final ‘dismantling of the NHS as we know it’, by bringing competition, markets, contracts, and private interests in to the NHS. The Bill’s turbulent journey through the Parliamentary process shows how controversial such a move was understood to be. This process also took place at a time when, in view of numerous inquiries, public trust in the ability of English healthcare institutions(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legalscholars;, and regulation specialists to consider key issues raised by the Act.",
author = "Victoria Chico and Hervey, {Prof Tamara} and Ruth Stirton and Amanda Warren-Jones",
note = "Papers delivered at the Inaugural Event funded by the Sheffield Health Law and Policy Research Centre, entitled 'Old Markets, New Markets: Health Law after the 2012 Act' (2013), which incorporated international speakers.",
year = "2014",
month = "6",
day = "1",
doi = "10.1093/medlaw/fwu013",
language = "English",
volume = "22",
pages = "157--161",
journal = "Medical Law Review",
issn = "0967-0742",
publisher = "Oxford University Press",
number = "Special Issue: 2",

}

Markets and Vulnerable Patients : Health Law After the 2012 Act. / Chico, Victoria; Hervey, Prof Tamara; Stirton, Ruth; Warren-Jones, Amanda.

In: Medical Law Review, Vol. 22, No. Special Issue: 2, 01.06.2014, p. 157-161.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Markets and Vulnerable Patients

T2 - Health Law After the 2012 Act

AU - Chico, Victoria

AU - Hervey, Prof Tamara

AU - Stirton, Ruth

AU - Warren-Jones, Amanda

N1 - Papers delivered at the Inaugural Event funded by the Sheffield Health Law and Policy Research Centre, entitled 'Old Markets, New Markets: Health Law after the 2012 Act' (2013), which incorporated international speakers.

PY - 2014/6/1

Y1 - 2014/6/1

N2 - In the popular imagination, the Health and Social Care Act 2012 is associated with a final ‘dismantling of the NHS as we know it’, by bringing competition, markets, contracts, and private interests in to the NHS. The Bill’s turbulent journey through the Parliamentary process shows how controversial such a move was understood to be. This process also took place at a time when, in view of numerous inquiries, public trust in the ability of English healthcare institutions(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legalscholars;, and regulation specialists to consider key issues raised by the Act.

AB - In the popular imagination, the Health and Social Care Act 2012 is associated with a final ‘dismantling of the NHS as we know it’, by bringing competition, markets, contracts, and private interests in to the NHS. The Bill’s turbulent journey through the Parliamentary process shows how controversial such a move was understood to be. This process also took place at a time when, in view of numerous inquiries, public trust in the ability of English healthcare institutions(in particular hospitals, but also nursing homes) to protect vulnerable patients against fundamental failures to provide compassionate care and treatment had been seriously undermined. This special issue brings together medical lawyers with those with an interest in health as a case study, but who self-define as: competition lawyers; EU lawyers; pharmaceutical and patent lawyers; comparative lawyers; bioethicists; empirical socio-legalscholars;, and regulation specialists to consider key issues raised by the Act.

U2 - 10.1093/medlaw/fwu013

DO - 10.1093/medlaw/fwu013

M3 - Editorial

VL - 22

SP - 157

EP - 161

JO - Medical Law Review

JF - Medical Law Review

SN - 0967-0742

IS - Special Issue: 2

ER -